Compliant Google Ads, SEO and AI search visibility for GLP-1, semaglutide, tirzepatide and physician-supervised weight loss programs. Built to win local patients from national telehealth brands without getting your ad account paused.
Get My Free AI Marketing AuditMedical weight loss turned into one of the fastest-growing patient categories in outpatient medicine the moment semaglutide and tirzepatide went mainstream. Search demand that did not exist three years ago is now fought over by national telehealth platforms, compounding pharmacies, primary care practices and med spas that added a GLP-1 program overnight.
Most of the clinics that call us have already tried running this themselves or through a generalist agency. The pattern is the same: ads disapproved for prescription-drug language, a landing page that reads like every telehealth site, and no idea what a booked consult actually costs. A GLP-1 marketing agency exists to fix exactly those three problems.
We run Google Ads inside Google's healthcare and medicines policy, write the semaglutide and tirzepatide content that gets a clinic cited in Google AI Overviews and ChatGPT, and report on cost per booked patient rather than clicks. Our clients are in-person and hybrid clinics, med spas with a medical director, and weight-loss-focused primary care practices across the U.S.
Physician-led programs offering semaglutide, tirzepatide, labs and ongoing monitoring. We position the in-person model as the safer, faster path and price the campaign to the lifetime value of a 12-month patient.
Aesthetic practices that added weight loss as a service line and need it to stand on its own: separate landing page, separate campaign, separate reporting, with medical supervision front and center.
Internal medicine, family practice and hormone therapy clinics where GLP-1 therapy is one program among several and the goal is a predictable flow of new weight loss consults without cannibalizing the rest of the practice.
Search campaigns built around medical weight loss and GLP-1 program intent, structured to stay inside Google's prescription-drug rules. Negative keyword lists that keep out job seekers, coupon hunters and telehealth comparison shoppers. Call tracking and form tracking tied to actual consults.
Medically accurate pages on semaglutide vs tirzepatide, side effects, cost, insurance and what happens after you stop. These are the questions patients research for weeks before booking, and the practice that answers them locally is the one they call.
Structured content, schema and entity work so your clinic is the one Google AI Overviews, ChatGPT and Perplexity name when a patient asks who offers GLP-1 weight loss near them. Most clinics are invisible here today.
Pages that explain the supervision model, show transparent program pricing, answer the telehealth comparison head-on and make booking a consult the obvious next step. Built for the ad traffic, not adapted from the homepage.
GLP-1 and medical weight loss added as services on your profile, review generation from weight loss patients specifically, and local content so the clinic ranks in the map pack for weight loss searches, where telehealth brands cannot appear.
Facebook and Instagram campaigns that comply with Meta's weight loss and personal-attributes rules. We add these once Google Search is maxed out in your market, because search intent converts first and Meta works best as the second step.
Google's healthcare and medicines policy restricts how prescription drugs can be promoted, and the restrictions tighten further for anything that looks like an online pharmacy or telehealth prescribing model. Meta has its own rules on weight loss claims, before-and-after imagery and personal-attribute targeting. None of this stops a legitimate clinic from advertising. It does mean the campaign has to be built by someone who has read the policies.
In practice: campaigns are built around the clinical service and the supervised program rather than drug brand names, landing pages describe the medical process rather than promising outcomes, and any certification Google or Meta requires for your model is sorted out before a dollar is spent. Clinics that skip this step find out when the account is suspended mid-month.
Traditional weight loss marketing sold diet programs, meal replacements and coaching to patients who had to be educated on the category. GLP-1 patients arrive already knowing the drug names, the mechanism and the rough monthly cost. They are not choosing whether to do it. They are choosing who to do it with, and they decide on access, monitoring and price transparency.
The competitive threat is national telehealth and compounding platforms with lower prices and bigger budgets. A local clinic's real advantage is what those platforms structurally cannot offer: an in-person exam, a same-week dose adjustment when nausea shows up, labs on site, and a physician who notices what an intake form misses. Marketing that makes that concrete converts. Marketing that says "personalized care" does not.
Pricing transparency has become a lever on its own. GLP-1 patients comparison-shop hard, and clinics that publish program pricing see lower bounce rates and higher-intent inquiries than clinics that make patients book a consult to learn the cost, even when the published price is not the lowest in the market.